Investigating the Origins of Biochemical Dysregulation in Trisomy 21 Pregnancy
The Journal of Clinical Endocrinology & Metabolism · 2025
DOI: 10.1210/clinem/dgaf339 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Angelika Buczyńska und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Centre, Medical University of Białystok, Białystok 15-276, Poland. Hauptthemen laut MEDLINE: Down Syndrome, Oxidative Stress. Die Arbeit nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Bialystok.
Abstract (Originalsprache)
Background and Aims Genetic profiling of trisomy 21 (T21) shows disruptions in energy homeostasis and oxidative stress pathways. This study aimed to evaluate oxidative and metabolic dysregulation in T21 pregnancies and identify their genetic or systemic origins.
Methods
After karyotype analysis, 20 women with T21 and 20 with euploid fetuses were enrolled. Inclusion criteria were referral for prenatal testing; exclusion criteria encompassed maternal chronic or acute diseases. Amniotic fluid and plasma samples were collected and total oxidative capacity (TOC), total antioxidant capacity (TAC), superoxide dismutase (SOD), nuclear factor-κB (NFκB), forkhead box O (FOXO), sirtuin 1 (SIRT1), 8-hydroxy-2′-deoxyguanosine (8-OHdG), leptin, and adiponectin levels were measured. The amniotic fluid/plasma (AF/P) ratio was calculated to assess marker origin.
Results
In T21 pregnancies, maternal plasma showed decreased levels of TAC, SOD, FOXO, and leptin (P < .05). In amniotic fluid, levels of FOXO and leptin were also reduced, while SOD, TAC, TOC, adiponectin, and 8-OHdG were elevated (P < .05). The AF/P ratio was increased for SOD (P = .027), TAC (P < .001), TOC (P < .0001), and adiponectin (P = .002), suggesting a fetal origin, while decreased SIRT1 levels (P = .036) indicate impaired fetal oxidative regulation. A plasma biomarker panel comprising SOD, TAC, and leptin, assessed via regression modeling, demonstrated the highest clinical utility in distinguishing T21 pregnancies from euploid pregnancies (area under the receiver operating characteristic curve = .92, P < .001).
Conclusion
The AF/P ratio supports a fetal origin for SOD, TAC, TOC, and adiponectin, while lower SIRT1 implies disrupted fetal oxidative regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Research Centre, Medical University of Białystok, Białystok 15-276, Poland.
- Clinical Research Support Centre, Medical University of Białystok, Białystok 15-276, Poland.
- Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Białystok, Białystok 15-276, Poland.
- Department of Gynecological Endocrinology and Adolescent Gynecology, Medical University of Białystok, Białystok 15-276, Poland.
ORCID-Profile: Angelika Buczyńska
Förderung
- Medical University of Bialystok
Zitieren
APA
Buczyńska, A., Sidorkiewicz, I., Krętowski, A. J., & Zbucka-Krętowska, M. (2025). Investigating the Origins of Biochemical Dysregulation in Trisomy 21 Pregnancy. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf339
Vancouver
Buczyńska A, Sidorkiewicz I, Krętowski AJ, Zbucka-Krętowska M. Investigating the Origins of Biochemical Dysregulation in Trisomy 21 Pregnancy. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgaf339
BibTeX
@article{Buczyska2025,
author = {Buczyńska, Angelika and Sidorkiewicz, Iwona and Krętowski, Adam Jacek and Zbucka-Krętowska, Monika},
title = {Investigating the Origins of Biochemical Dysregulation in Trisomy 21 Pregnancy},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
doi = {10.1210/clinem/dgaf339}
}
EUVIMED